Biomarkers in Sporadic and Familial Alzheimer's Disease

Manuscript Number: 

14-3006R1

Author(s): 
Kaj Blennow, Bruno Dubois, Harald Hampel, Jacques Hugon, Simone Lista, Sid E. O’Bryant, Henrik Zetterberg

Disclosures

Kaj Blennow

  • Consulting Fees:
    Dr. Blennow has served at Advisory Boards for IBL International and Eli-Lilly, and as a consultant for Roche Diagnostics and Novartis.

Bruno Dubois

  • Consulting Fees:
    ELi Lilly
    Grants
    • Agency: 
      Pfizer
      Dates: 
      2010

Harald Hampel

  • Consulting Fees:
    Boehringer-Ingelheim, Elan Corporation, Novartis, Eisai Inc., Pfizer, Schwabe, Sanofi-Aventis, Roche Pharmaceuticals and Diagnostics, GE Healthcare, Astra-Zeneca, Avid, Eli Lilly and Company, Jung-Diagnostics, Cytox.
    Lecture Fees:
    Novartis, Eisai Inc., Pfizer, Schwabe, GE Healthcare, Eli Lilly and Company, Janssen-Cilag, Merz Pharmaceuticals, GlaxoSmithKline-Biologicals.
    Patents/Royalties
    Patent (pending): "Method for predicting whether sujects with mild cognitive impairment (MCI) will develop Alzheimer's disease" Date of submission: 7/11/2003 Inventor: Hampel H, Kerkman D, DeBernadis JF, Zinkowski R Running Number: PCT/US03/35516 Case-Number 02-1191-B Patent (pending): "Method for predicting whether sujects with mild cognitive impairment (MCI) will develop Alzheimer's disease" Date of submission: 24/05/2005 Patent application: Osler, Hoskin, Harcourt, LLD, Ottawa, Ontario, Canada Inventor: Kerkman D, DeBernadis JF, Zinkowski R, Hampel H Running Number: PCT/US03/35516 Case-Number 60/424,628 Patent (pending): "Method for predicting whether sujects with mild cognitive impairment (MCI) will develop Alzheimer's disease" Date of submission: 24/05/2005 Inventor: Kerkman D, DeBernadis JF, Zinkowski R, Hampel H Running Number: PCT/US03/35516 Case-Number 60/424,628 Patent (pending): "3-Hydroxykynurenin im Serum als diagnotischer Marker für die Demenz vom Alzheimer-Typ" Date of submission: 06/03/2006 Patent application: Fa. DiaMed, Switzerland Inventor: Schwarz M, Hampel H, Müller N, Teipel SJ, Bürger K, Zach, J Running Nummer: PCT/EP2006/002907 Case-Number: N.N Patent (pending): "Neurodegenerative markers for psychiatric condtions" Date of submission: 30/03/2006 Patent appplication: Fa. DiaMed Eurogen, Belgium Inventor: Myint AM, Schawaller M, Verkerk R, Schwaz MJ, Hampel H. Müller N Running Numer: EP2006002907 Case-Number: 06723873.3-1223 Patent (pending): "Ratio Aß42/40 im Plasma in der Früh- und Differentialdiagnose der Alzheimer Krankheit" Date of submission: 15/12/2006 Patent application:Fa. The Genetics, Switzerland Inventor: Bürger K, Hampel H, Teipel SJ Running Number: IIIB8/823/06 Case-Number: N.N. Patent (pending): "Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz Erkrankungen und neuroinflammatorischen Erkrankungen" Date of submission: 24/07/2006 Inventor: Bergmann A, Ernst A, Hampel H Running Number: PCT/EP2006007141 Case-Number: 06776308.6-2404 Patent (pending): "In vitro Verfahren zur Diagnose von neurodegenerativen Erkrankungen" Date of submission: 24/07/2006 Inventor: Bergmann A, Ernst A, Hampel H Running Number: PCT/EP2006007272 Case-Number: 06762778.6-2404 Patent (pending): "In vitro Verfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen" Date of Submission: 28/11/2007 Inventor: Bergmann A, Ernst A, Hampel H Running Number: PCT/EP2007010331 Case-Number: 07856296.4-2404
    Grants
    • Agency: 
      AXA Research Fund
      Dates: 
      Starting from 09-2013

Jacques Hugon

  • Consulting Fees:
    For the last 3 years consultant for ROCHE, NOVARTIS,
    Grants
    • Agency: 
      SANOFI
      Dates: 
      2013
    • Agency: 
      XIGEN
      Dates: 
      2014

Simone Lista

  • Nothing to Disclose

Sid E. O’Bryant

  • Nothing to Disclose

Henrik Zetterberg

  • Nothing to Disclose